Evista(Raloxifene) Instructions:Uses,Dosage, Side Effects

Treatment and prevention of osteoporosis in postmenopausal women.

Reduction of the risk of invasive breast cancer in postmenopausal women with osteoporosis.

Reduction of the risk of invasive breast cancer in postmenopausal women identified as being at high risk for invasive breast cancer.

Important Limitations: Not indicated for treatment of invasive breast cancer, reduction of breast cancer recurrence risk, or reduction of noninvasive breast cancer risk.

The recommended dosage is one 60 mg tablet taken orally once daily.

Administration can occur at any time of day, with or without food.

For invasive breast cancer risk reduction, the optimal treatment duration is not definitively established.

Patients should receive supplemental calcium and vitamin D if their daily dietary intake is insufficient.